Gene · 865
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I. | Viruses | 2023 | 36851677 | PubTator, text mining | PubMed |
| Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia. | Exp Hematol Oncol | 2023 | 36849955 | PubTator, text mining | PubMed |
| Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients. | Front Oncol | 2023 | 36845715 | PubTator, text mining | PubMed |
| Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia. | Ann Lab Med | 2023 | 36843401 | PubTator, text mining | PubMed |
| The Role of Consumption of Molybdenum Biofortified Crops in Bone Homeostasis and Healthy Aging. | Nutrients | 2023 | 36839380 | PubTator, text mining | PubMed |
| Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML. | Int J Mol Sci | 2023 | 36834477 | PubTator, text mining | PubMed |
| Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer. | Cancers (Basel) | 2023 | 36831644 | PubTator, text mining | PubMed |
| An Integrative Analysis of Nasopharyngeal Carcinoma Genomes Unraveled Unique Processes Driving a Viral-Positive Cancer. | Cancers (Basel) | 2023 | 36831585 | PubTator, text mining | PubMed |
| The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context. | Cells | 2023 | 36831308 | PubTator, text mining | PubMed |
| Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer. | Biomolecules | 2023 | 36830717 | PubTator, text mining | PubMed |
| Research progress on molecular biomarkers of acute myeloid leukemia. | Front Oncol | 2023 | 36824144 | PubTator, text mining | PubMed |
| Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia. | Leukemia | 2023 | 36823395 | PubTator, text mining | PubMed |
| GSK3 inhibitor enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance. | EJHaem | 2023 | 36819180 | PubTator, text mining | PubMed |
| Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis. | Front Immunol | 2023 | 36817493 | PubTator, text mining | PubMed |
| Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia. | Front Pharmacol | 2023 | 36817152 | PubTator, text mining | PubMed |
| Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. | Haematologica | 2023 | 36815378 | PubTator, text mining | PubMed |
| Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea. | Hum Genomics | 2023 | 36814285 | PubTator, text mining | PubMed |
| SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities. | Mol Cancer | 2023 | 36810086 | PubTator, text mining | PubMed |
| In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation. | Nat Med | 2023 | 36807684 | PubTator, text mining | PubMed |
| Hematopoietic stem cell aging and leukemia transformation. | Blood | 2023 | 36800569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/865/papers?page=19